Kura Oncology, Inc. - Common Stock (KURA)

CUSIP: 50127T109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
88,399,441
Total 13F shares
67,619,494
Share change
-948,953
Total reported value
$1,409,907,095
Put/Call ratio
35%
Price per share
$20.85
Number of holders
163
Value change
-$33,759,405
Number of buys
84
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
10%
9,179,469
$259,503,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
5.9%
5,223,546
$147,669,000 31 Mar 2021
13F
Avoro Capital Advisors LLC
13F
Company
4.5%
4,000,000
$113,080,000 31 Mar 2021
13F
EcoR1 Capital, LLC
13F
Company
4.2%
3,692,637
$104,391,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
3.8%
3,328,408
$94,094,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
3.2%
2,833,650
$80,107,000 31 Mar 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
2.8%
2,474,145
$69,944,000 31 Mar 2021
13F
Holocene Advisors, LP
13F
Company
2.5%
2,241,352
$63,363,000 31 Mar 2021
13F
Foresite Capital Management IV, LLC
13F
Company
2.1%
1,849,947
$52,298,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
1.9%
1,695,212
$47,924,000 31 Mar 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.9%
1,687,618
$47,709,000 31 Mar 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
1.9%
1,671,574
$47,255,000 31 Mar 2021
13F
BVF INC/IL
13F
Company
1.8%
1,635,112
$46,225,000 31 Mar 2021
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
1.8%
1,617,573
$45,729,000 31 Mar 2021
13F
CITADEL ADVISORS LLC
13F
Company
1.6%
1,435,217
$40,574,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
1,087,457
$30,742,000 31 Mar 2021
13F
RTW INVESTMENTS, LP
13F
Company
1.2%
1,081,912
$30,586,000 31 Mar 2021
13F
Boxer Capital, LLC
13F
Company
1.2%
1,050,289
$29,692,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.2%
1,044,008
$29,514,000 31 Mar 2021
13F
S.c.a. Candriam
13F
Individual
1.1%
929,277
$29,153,000 31 Mar 2021
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.96%
845,190
$24,785,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.93%
819,092
$23,104,000 31 Mar 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.84%
741,764
$20,970,000 31 Mar 2021
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
732,415
$20,705,000 31 Mar 2021
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.81%
717,751
$20,291,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.81%
716,413
$20,253,000 31 Mar 2021
13F
Rock Springs Capital Management LP
13F
Company
0.8%
710,035
$20,073,000 31 Mar 2021
13F
HHLR ADVISORS, LTD.
13F
Company
0.74%
650,000
$18,376,000 31 Mar 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.72%
633,400
$17,906,000 31 Mar 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.69%
608,283
$17,196,000 31 Mar 2021
13F
Artal Group S.A.
13F
Company
0.68%
600,000
$16,962,000 31 Mar 2021
13F
Ghost Tree Capital, LLC
13F
Company
0.68%
600,000
$16,962,000 31 Mar 2021
13F
VR Adviser, LLC
13F
Company
0.65%
575,000
$16,255,000 31 Mar 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.61%
536,820
$15,176,000 31 Mar 2021
13F
Vivo Capital, LLC
13F
Company
0.59%
525,262
$14,849,000 31 Mar 2021
13F
Commodore Capital LP
13F
Company
0.59%
521,555
$14,744,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.5%
443,227
$12,531,000 31 Mar 2021
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.45%
400,000
$11,308,000 31 Mar 2021
13F
Affinity Asset Advisors, LLC
13F
Company
0.41%
365,000
$10,319,000 31 Mar 2021
13F
Polar Capital Holdings Plc
13F
Company
0.4%
350,000
$9,895,000 31 Mar 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.39%
347,190
$9,815,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.37%
325,104
$9,191,000 31 Mar 2021
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.34%
299,976
$8,480,321 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.34%
298,342
$8,434,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.33%
289,919
$8,196,000 31 Mar 2021
13F
Asymmetry Capital Management, L.P.
13F
Company
0.31%
277,468
$7,844,000 31 Mar 2021
13F
Tekla Capital Management LLC
13F
Company
0.31%
273,463
$7,731,000 31 Mar 2021
13F
Sio Capital Management, LLC
13F
Company
0.24%
213,471
$6,035,000 31 Mar 2021
13F
Verition Fund Management LLC
13F
Company
0.22%
195,085
$5,515,000 31 Mar 2021
13F
AXA S.A.
13F
Company
0.2%
176,411
$4,987,000 31 Mar 2021
13F

Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2021

As of 30 Jun 2021, Kura Oncology, Inc. - Common Stock (KURA) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,619,494 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, Holocene Advisors, LP, AMERIPRISE FINANCIAL INC, WELLINGTON MANAGEMENT GROUP LLP, and Foresite Capital Management IV, LLC. This page lists 163 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
162
Q2 2021 holders
163
Holder diff
1
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .